Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.450
-0.010 (-0.68%)
At close: Nov 13, 2026, 4:00 PM EST
1.480
+0.030 (2.07%)
After-hours: Nov 13, 2026, 7:04 PM EST
Acrivon Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $8 | Buy | Reiterates | $8 | +451.72% | Nov 11, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $7 | Buy | Maintains | $7 | +382.76% | Nov 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $8 | Buy | Maintains | $8 | +451.72% | Aug 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $19 | Buy | Maintains | $19 | +1,210.34% | Aug 13, 2026 |
| Gabelli No rating | Gabelli | Buy Initiates $8 | Buy | Initiates | $8 | +451.72% | Jun 15, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |